| 000 | 01217 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516152705.0 | ||
| 264 | 0 | _c20140428 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1179-1926 | ||
| 024 | 7 |
_a10.1007/s40262-013-0076-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Leeuwen, N | |
| 245 | 0 | 0 |
_aThe role of pharmacogenetics in drug disposition and response of oral glucose-lowering drugs. _h[electronic resource] |
| 260 |
_bClinical pharmacokinetics _cOct 2013 |
||
| 300 |
_a833-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 |
_aDipeptidyl-Peptidase IV Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 |
_aGlucagon-Like Peptide 1 _xanalogs & derivatives |
| 650 | 0 | 4 | _aGlycoside Hydrolase Inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aThiazolidinediones _xpharmacology |
| 700 | 1 | _aSwen, J J | |
| 700 | 1 | _aGuchelaar, H-J | |
| 700 | 1 | _a't Hart, L M | |
| 773 | 0 |
_tClinical pharmacokinetics _gvol. 52 _gno. 10 _gp. 833-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40262-013-0076-3 _zAvailable from publisher's website |
| 999 |
_c22791801 _d22791801 |
||